US Patent 11014884 Modulators of hemoglobin
Patent 11014884 was granted and assigned to Global Blood Therapeutics on May, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 30, 2019
Date of Patent
May 25, 2021
Patent Applicant
Patent Application Number
16588753
Patent Citations
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11014884 Modulators of hemoglobin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
